GENE-THERAPY FOR NEURODEGENERATIVE DISORDERS AND MALIGNANT BRAIN-TUMORS

Gene therapy approaches have great promise in the treatment of neurode generative disorders and malignant brain tumors. Neuwelt et al. review available viral-mediated gene therapy methods and their blood-brain-b arrier (BBB) disruption delivery technique, briefly mentioning nonvira l mediated gene therapy methods. This commentary discussed the BBB dis ruption delivery technique, viral and nonviral mediated gene therapy a pproaches to Parkinson's disease, and the potential use of antisense o ligo to suppress malignant brain tumors.